arrow
P

Pier Luigi Lopalco

university of salento
H指数:45
被引数:6,755

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024–2025

Nirsevimab在预防RSV住院治疗中的真实世界有效性:2024–2025年意大利南部婴儿的保护证据

2025-10-300
OAAI
Cost of universal immunization with Nirsevimab vs. standard of practice for infants in their first RSV season. Foggia District, Italy, 2023–2024

与标准实践相比,在首次RSV季节对婴儿进行Nirsevimab普遍免疫的成本。意大利福贾区,2023–2024。

Vaccine
IF3.5
2025-07-310
PRE
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic

评估意大利孕妇的疫苗接种意愿和认知:一项在强制政策与COVID-19疫情背景下开展的多中心横断面研究

Vaccine
IF3.5
2025-07-310
OA
Assessing vaccine hesitancy and health literacy using a new Italian vaccine confidence index and a modified Italian medical term recognition test: A cross-sectional survey on Italian parents
2023-10-312
OAAI
Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study
2023-05-041
OAAI
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection (vol 23, 1, 2023)
2023-02-161
OAAI